Related references
Note: Only part of the references are listed.Prevalence of statin intolerance: a meta-analysis
Ibadete Bytyci et al.
EUROPEAN HEART JOURNAL (2022)
Statin intolerance: how common is it and how do we work with patients to overcome it?
Christopher P. Cannon
EUROPEAN HEART JOURNAL (2022)
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials
Ulrich Laufs et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2022)
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
Maciej Banach et al.
PHARMACOLOGICAL RESEARCH (2022)
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M. Ballantyne et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A. Wood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (vol 41, pg 111, 2019)
F. Mach
EUROPEAN HEART JOURNAL (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (vol 41, pg 111, 2019)
F. Mach
EUROPEAN HEART JOURNAL (2020)
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion
Maciej Banach et al.
ATHEROSCLEROSIS SUPPLEMENTS (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy et al.
CIRCULATION (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
Management of Statin Intolerance in 2018: Still More Questions Than Answers
Peter P. Toth et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
Christie M. Ballantyne et al.
ATHEROSCLEROSIS (2018)
Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience
Natalie C. Ward et al.
CLINICAL CARDIOLOGY (2018)
Characteristics of patients prescribed Evolocumab in Europe. Does clinical use match clinical guidelines?
K. Ray et al.
EUROPEAN HEART JOURNAL (2018)
Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations
Albert Selva-O'Callaghan et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Does Googling lead to statin intolerance?
Sarah Khan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
The Role of Nutraceuticals in Statin Intolerant Patients
Maciej Banach et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
Francois Mach et al.
EUROPEAN HEART JOURNAL (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Statin-associated muscle symptoms-Managing the highly intolerant
James M. Backes et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F. G. Cicero et al.
NUTRITION REVIEWS (2017)
Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management
T. P. Johnston et al.
PHARMACOLOGICAL RESEARCH (2017)
Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents
Natalie Ward et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence
Vivencio Barrios et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Statin tolerability: In defence of placebo-controlled trials
Jonathan A. Tobert et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome The IMPROVE-IT Trial
Sabina A. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Lipid-modifying effects of nutraceuticals: An evidence-based approach
Amirhossein Sahebkar et al.
NUTRITION (2016)
Statin Intolerance: A Literature Review and Management Strategies
David R. Saxon et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials
Jesus Millan et al.
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS (2016)
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Patrick M. Moriarty et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nutraceuticals for the treatment of hypercholesterolemia
Massimo R. Mannarino et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?
Helen I. Keen et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients The GAUSS Randomized Trial
David Sullivan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Mevalonate pathway: A review of clinical and therapeutical implications
Irina Buhaescu et al.
CLINICAL BIOCHEMISTRY (2007)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Share Paper
